Wednesday, June 10, 2026

pharma · Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) · IgA Nephropathy (IgAN) · VERA

Vera Therapeutics

NovaPharmaNews editorial coverage mentioning Vera Therapeutics — regulatory, clinical, and market analysis.

4539 Metropolitan Ct, Frederick, Maryland 21704, US HQ
2018 Founded
9 Employees
Public company Type
VERA · NYSE Ticker
Company details
Status
Public
HQ
4539 Metropolitan Ct, Frederick, Maryland 21704, US
Founded
2018
Employees
9
Programs
25
Drugs
32
Patents
140
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Vera Therapeutics — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Vera Therapeutics — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Vera Therapeutics yet.

Back to company overview →